Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.
Press releases published on July 11, 2025
Accel Atoms AI and Atoms X scaling programs to offer Indian-origin founders up to $1M
GlobeNewswire
·
July 11, 2025
Bengaluru, July 11, 2025 (GLOBE NEWSWIRE) -- Accel, a leading global venture capital firm, today announced an expansion of its pre-seed scaling program with the launch of two tracks - Accel Atoms AI and Accel Atoms X. Open to Indian and Indian-origin …
re:cap lands in the UK to scale its Capital OS for tech companies, as it secures €125M for new facility
GlobeNewswire
·
July 11, 2025
Berlin, July 11, 2025 (GLOBE NEWSWIRE) -- As the tech industry pivots from growth-at-all-costs to a new era of capital efficiency, founders and CFOs are under pressure to rethink how they fund and manage growth. re:cap, the Berlin-based fintech behind the …
Viewbix: Metagramm Unveils AI-Powered Grammar Solution for Enterprises Seeking Secure, Private, and Customized Language Models
GlobeNewswire
·
July 11, 2025
New on-premises grammar engine to revolutionize enterprise language accuracy using proprietary data Tel Aviv, Israel, July 11, 2025 (GLOBE NEWSWIRE) -- Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), a global developer of ad-tech innovative …
BriaCell’s Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer
GlobeNewswire
·
July 11, 2025
Median Overall Survival (OS) of 13.9 months in triple negative breast cancer (TNBC) exceeds Trodelvy (11.8 months) and doubles control (6.9 months) OS of 17.3 months in HR+ metastatic breast cancer surpasses Trodelvy (14.4 months) and control (11.2 months) …
Zevra Therapeutics Announces MIPLYFFA® (arimoclomol) Featured in Presentations at the National Niemann Pick Disease Foundation Conference
GlobeNewswire
·
July 11, 2025
CELEBRATION, Fla., July 11, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, today announced an oral presentation and …
MiNK Therapeutics Announces Publication of Complete Remission Following Allogeneic iNKT Cell Therapy in Metastatic Testicular Cancer
GlobeNewswire
·
July 11, 2025
NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell therapies, today announced the publication of another …
Laser Systems and Components Market Sees Strong Global Growth
GlobeNewswire
·
July 11, 2025
Boston, July 11, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Global Markets for Laser Systems, Components and Materials" is expected to grow from $21.0 billion in 2024 to reach $30.4 billion by the end of 2029, at a …
Constellium to Report Second Quarter 2025 Results on July 29, 2025
GlobeNewswire
·
July 11, 2025
PARIS, July 11, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) will host a conference call and webcast on Tuesday, July 29, 2025, at 10:00 AM (Eastern Time) to announce its second quarter 2025 results. The press release will be sent before market …
Coffee Market Size Worth USD 381.52 Billion by 2034
GlobeNewswire
·
July 11, 2025
Ottawa, July 11, 2025 (GLOBE NEWSWIRE) -- According to Precedence Research, the worldwide coffee market size was estimated at $245.2 billion in 2024, rising from its current value of nearly $256.29 billion. The imports and exports of certified coffees …
Bombardier’s Blazing Fast Global 7500 Jet Sets its 135th City-Pair Speed Record, the Most Ever Achieved by a Single Business Aircraft Type
GlobeNewswire
·
July 11, 2025
Industry flagship stands alone as the most decorated record-setting business jet of all time, solidifying its position as the leader of the ultra-long-range class The record-breaking aircraft has set 135 city-pair missions, further highlighting its …
L’ultrarapide avion d’affaires Global 7500 de Bombardier établit son 135e record de vitesse lors d’une liaison, soit le plus grand nombre pour un seul type d’avion d’affaires
GlobeNewswire
·
July 11, 2025
L’avion phare de l’industrie se démarque comme l’avion d’affaires ayant enregistré le plus de records, renforçant sa position de chef de file dans la catégorie des très long-courriers L’avion aux exploits record a effectué 135 missions de liaisons, ce qui …
Signing Day Sports Advances Business Combination with One Blockchain LLC; Confidential Draft Registration Statement on Form S-4 Submitted to the SEC, Including Preliminary Prospectus and Proxy Statement
GlobeNewswire
·
July 11, 2025
SCOTTSDALE, AZ, July 11, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), the developer of the Signing Day Sports app and platform dedicated to improving the recruiting process for high school …
Orezone Lodges Prospectus to Raise A$75 Million as Part of ASX Listing
GlobeNewswire
·
July 11, 2025
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 11, 2025 (GLOBE NEWSWIRE) -- Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to announce that …
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
GlobeNewswire
·
July 11, 2025
FDA issued Complete Response Letter Capricor plans to resubmit its BLA to include data from the ongoing Phase 3 HOPE-3 trial in Q3 2025 to continue pursuing the indication for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy FDA …
Milestone Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire
·
July 11, 2025
MONTREAL, Quebec and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST) today announced that it has commenced an underwritten public offering (the “Offering”) of its common shares, accompanying …
Milestone Pharmaceuticals Announces FDA Acceptance of the Company’s Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray
GlobeNewswire
·
July 11, 2025
New PDUFA Action Date of December 13, 2025 $75 Million Royalty Purchase Agreement Payment from RTW Extended Through 2025 MONTREAL and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) (Milestone) today …
Aurora Mobile Evaluates Solana (SOL) for its Cryptocurrency Treasury Strategy
GlobeNewswire
·
July 11, 2025
SHENZHEN, China, July 11, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) ("Aurora Mobile" or the "Company"), a leading provider of customer engagement and marketing technology services in China, today announced that it is evaluating the …
e-therapeutics reduziert Risiken im klinischen Verfahren für GalOmic-Kandidaten ETX-312 dank positiver Ergebnisse in der vorklinischen Phase
GlobeNewswire
·
July 11, 2025
ETX-312 wurde in GLP-konformen Toxikologiestudien in überhöhten Dosierungen gut vertragen GMP-konforme Herstellung einer Charge für klinische Studien erfolgreich abgeschlossen Auf Kurs für die Einreichung bei der CTA im vierten Quartal 2025 LONDON, July 11 …
e-therapeutics sécurise le développement clinique de son candidat GalOmic ETX-312 grâce à des données non cliniques positives
GlobeNewswire
·
July 11, 2025
ETX-312 bien toléré à des doses élevées lors d’études de toxicologie conformes aux normes BPL Fabrication du lot destiné à l’essai clinique achevée avec succès conformément aux normes BPF Soumission de la demande d’autorisation d’essai clinique en bonne …
Italfarmaco Presents New Cardiac Data for Givinostat at 16th European Paediatric Neurology Society (EPNS) Congress
GlobeNewswire
·
July 11, 2025
In total, 11 abstracts on givinostat were accepted for presentation at the Congress, including two for an oral presentation MILAN, Italy, July 11, 2025 – Italfarmaco S.p.A. announced today that new cardiac data for givinostat, a novel histone deacetylase …